Pressure Ulcers Treatment Market Report 2025

This Pressure Ulcers Treatment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The pressure ulcers treatment market size has grown strongly in recent years. It will grow from $5.38 billion in 2024 to $5.71 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the rising patent pool worldwide to augment growth, expansion of home healthcare services and telemedicine, increasing aging population, rising incidence of chronic diseases, and growing demand for innovative and cost-effective wound care products.

The pressure ulcers treatment market size is expected to see strong growth in the next few years. It will grow to $7.18 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to the aging population, rising incidence of chronic disease, technological advancement, regenerative medicine, and increasing research and development. Major trends in the forecast period include 3D printing, advanced foam dressing, nutritional interventions, remote monitoring, and AI and machine learning.

The increasing diabetic population is anticipated to drive the growth of the pressure ulcer treatment market. The diabetic population refers to individuals diagnosed with diabetes mellitus, a chronic condition marked by high blood glucose levels. This population is expanding due to widespread lifestyle and dietary changes that lead to obesity and insulin resistance, key risk factors for diabetes. Diabetic individuals are more susceptible to pressure ulcers because of complications such as reduced sensation, impaired circulation, and slower wound healing, creating a greater need for effective treatments and management solutions in the market. For example, in December 2023, the Australian Bureau of Statistics, an Australian government agency responsible for data collection and analysis, reported that in 2022, diabetes affected one in twenty people, or 5.3%, totaling around 1.3 million individuals. Diabetes rates were similar between males and females, at 5.8% and 4.9%, respectively. That same year, diabetes ranked as the seventh leading cause of death in Australia, with 6,050 fatalities. Additionally, Type 2 diabetes was the twelfth largest contributor to the country’s disease burden, at 4.8%. Therefore, the rise in the diabetic population is fueling growth in the pressure ulcer treatment market.

Leading companies in the pressure ulcer treatment market are focusing on developing advanced wound care solutions, such as biosynthetic cellulose dressings, to promote healing, reduce infection risks, and improve patient outcomes in the management of chronic wounds. Biosynthetic cellulose dressings are innovative products made from bioengineered cellulose, offering excellent moisture retention, biocompatibility, and antimicrobial properties that enhance healing and protect against infections in chronic wounds like pressure ulcers. For example, in June 2023, JeNaCell, a Germany-based biotech company under Evonik, introduced the Epicite wound dressing. This dressing is specifically designed and optimized for treating chronic wounds with low to moderate exudation, including venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue injuries. Epicite balance is available in three sizes and will be distributed to hospitals and home care settings. Made from biosynthetic cellulose, a hydrophilic polymer designed for advanced medical applications, this dressing offers superior wound cleansing and helps stimulate the healing process in slow-healing wounds.

In May 2023, LifeNet Health, a U.S.-based medical company, acquired the wound care division of Bioventus Inc. for an undisclosed amount. This acquisition enhances LifeNet Health's position as a global leader in regenerative medicine by expanding its range of advanced wound care solutions. Bioventus Inc., a U.S.-based company, provides advanced wound care products specifically for treating pressure ulcers.

Major companies operating in the pressure ulcers treatment market are Cardinal Health, 3M Company, Medtronic plc, Stryker Corporation, Baxter International Inc, Medline Industries Inc, Smith & Nephew, Coloplast Corporation, B. Braun Medical Inc, Mölnlycke Health Care, Integra LifeSciences, Agiliti Health Inc, Arjo AB, Healogics Inc, EHOB Inc, Alimed Inc, Talley Group Ltd, Axio Biosolutions, Advancis Medical, Pegasus Healthcare, Lohmann & Rauscher.

North America was the largest region in the pressure ulcers treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pressure ulcers treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pressure ulcers treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pressure ulcer treatment encompasses medical and therapeutic strategies designed to heal and manage wounds resulting from prolonged pressure on the skin, typically over bony areas. This treatment involves relieving pressure, ensuring proper nutrition, and providing detailed wound care to support healing and prevent infection. The goal is to enhance patient comfort, improve quality of life, and prevent recurrence through customized interventions and patient education.

The primary types of pressure ulcer treatment include wound care dressings, wound care devices, active therapies, and other methods. Wound care dressings are materials placed directly on wounds to aid healing and protect against infection. Treatment is categorized by stages, stage 1, stage 2, stage 3, and stage 4. Key end-users of these treatments include hospitals and clinics, community healthcare centers, homecare settings, and other healthcare facilities.

The pressure ulcers treatment market research report is one of a series of new reports that provides pressure ulcers treatment market statistics, including pressure ulcers treatment industry global market size, regional shares, competitors with an pressure ulcers treatment market share, detailed pressure ulcers treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pressure ulcers treatment industry. This pressure ulcers treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pressure ulcers treatment market consists of revenues earned by entities by providing services such as wound care management, specialized dressings, pressure redistribution surfaces, nutritional support, and rehabilitation therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pressure ulcers treatment market also includes sales of medical equipment, wound dressings, and pressure-relieving mattresses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.